This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clendenning, M. Articles by de la Chapelle, A. Search for Related Content PubMed PubMed Citation Articles by Clendenning, M. Articles by de la Chapelle, A.

Origins and Prevalence of the American Founder Mutation of MSH2

¹ Human Cancer Genetics Program and ² Department of Internal Medicine, Comprehensive Cancer Center and ³ Mathematical Biosciences Institute, The Ohio State University, Columbus, Ohio; ⁴ Department of Preventive Medicine, Creighton University School of Medicine, Omaha, Nebraska; and ⁵ Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota

Requests for reprints: Albert de la Chapelle, Human Cancer Genetics, Room 804, Biomedical Research Tower, 460 West 12th Avenue, Columbus, OH 43210. Phone: 614-688-4781; Fax: 614-688-4772; E-mail: albert.delachapelle{at}osumc.edu.

Key Words: Lynch syndrome • AFM • genealogy • mutation age • population genetics

Large germline deletions within the mismatch repair gene MSH2 account for a significant proportion (up to 20%) of all deleterious mutations of this gene which are associated with Lynch syndrome. An exons 1 to 6 deletion of MSH2, originally reported in nine families, has been associated with a founding event within the United States, which genealogic studies had previously dated to 1727, and the number of present day carriers was estimated to be 18,981. Here, we report the development of a robust multiplex PCR which has assisted in the detection of 32 new families who carry the MSH2 American Founder Mutation (AFM). By offering testing to family members, 126 carriers of the AFM have been identified. Extensive genealogic studies have connected 27 of the 41 AFM families into seven extended pedigrees. These extended families have been traced back to around the 18th century without any evidence of further convergence between them. Characterization of the genomic sequence flanking the deletion and the identification of a common disease haplotype of between 0.6 and 2.3 Mb in all probands provides evidence for a common ancestor between these extended families. The DMLE+2.2 software predicts an age of 500 years (95% confidence interval, 425–625) for this mutation. Taken together, these data are suggestive of an earlier founding event than was first thought, which likely occurred in a European or a Native American population. The consequences of this finding would be that the AFM is significantly more frequent in the United States than was previously predicted. [Cancer Res 2008;68(7):2145–53]

This article has been cited by other articles:

				H. T. Lynch, Z. Gatalica, and J. Knezetic Molecular Genetics and Hereditary Colorectal Cancer: Resolution of the Diagnostic Dilemma of Hereditary Nonpolyposis Colorectal Cancer, Lynch Syndrome, Familial Colorectal Cancer Type X, and Multiple Polyposis Syndromes ASCO Educational Book, January 1, 2009; 2009(1): 221 - 226. [Abstract] [Full Text] [PDF]